Persistent Asset Partners LTD Recursion Pharmaceuticals, Inc. Transaction History
Persistent Asset Partners LTD
- $121 Billion
- Q4 2024
A detailed history of Persistent Asset Partners LTD transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 906 shares of RXRX stock, worth $9,377. This represents 0.14% of its overall portfolio holdings.
Number of Shares
906Holding current value
$9,377% of portfolio
0.14%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RXRX
# of Institutions
338Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$352 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$335 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$257 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$179 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$152 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.87B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...